CORDARONE

This brand name is authorized in Australia, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug CORDARONE contains one active pharmaceutical ingredient (API):

1 Amiodarone
UNII 976728SY6Z - AMIODARONE HYDROCHLORIDE

Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.

Read about Amiodarone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CORDARONE X Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CORDARONE X 100 Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01BD01 Amiodarone C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2343H, 2344J
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01408051, 02156723, 02235693, 02235701, 02235718, 16582211, 16582234, 16582240
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 23.175-1-04-07
Country: EE Ravimiamet Identifier(s): 1016233, 1016244, 1730753
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 142307, 421180
Country: FR Base de données publique des médicaments Identifier(s): 60662396, 62305927, 64408662, 68973926
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 13396, 13423, 209123
Country: HK Department of Health Drug Office Identifier(s): 27294, 27296
Country: IT Agenzia del Farmaco Identifier(s): 025035015
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1000504, 1016571, 1088663, 1092754
Country: MT Medicines Authority Identifier(s): MA1359/01401, MA1359/01402
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 148M81, 276M81
Country: NL Z-Index G-Standaard Identifier(s): 15731839
Country: NL Z-Index G-Standaard, PRK Identifier(s): 25119
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 3467, 3468, 3469
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100015820, 100015850, 100272557, 100274119, 100326862, 100330881, 100334206, 100338322, 100339824, 100344506, 100346586, 100346764, 100377894, 100385741, 100413800, 100429697, 100456045
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64483001, W64483002
Country: SG Health Sciences Authority Identifier(s): 00852P, 09784P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 6260032, 9263071
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699809018020, 8699809759107
Country: ZA Health Products Regulatory Authority Identifier(s): P/6.2/165, S/6.2/384

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.